Skip to main content
Saniona logo

Saniona — Investor Relations & Filings

Ticker · SANION ISIN · SE0005794617 LEI · 549300XO4L9XNOCFCZ84 ST Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2023-04-28 Annual Report
Country SE Sweden
Listing ST SANION

About Saniona

http://saniona.com

Saniona is a clinical-stage biopharmaceutical company focused on the research and development of treatments for neurological disorders, with a primary emphasis on epilepsy. The company is a leader in the field of ion channel modulation, leveraging its expertise and a proprietary drug discovery engine to create new medicines. Saniona has developed an extensive library of over 20,000 proprietary molecules designed to target various ion channels. Its pipeline includes multiple potential new medicines advancing through clinical trials, with the goal of addressing unmet medical needs for patients with central nervous system diseases.

Recent filings

Filing Released Lang Actions
Annual Report 2022
Annual Report Classification · 100% confidence The document is titled 'ÅRSREDOVISNING 2022' which translates to 'Annual Report 2022' for Saniona AB. It contains detailed financial data such as revenues, operating costs, net results, earnings per share, and cash balances. It also includes a letter from the CEO, a business overview, pipeline information, risk factors, financial statements, notes to the financial statements, and auditor's report. The length is substantial (15,000 characters) and the content is comprehensive, covering the full fiscal year 2022. This matches the definition of an Annual Report (10-K) which is an official yearly report covering company activity and full financial performance. There is no indication that this is merely an announcement or a certification, nor is it a quarterly or interim report. Therefore, the correct classification is Annual Report (10-K). FY 2022
2023-04-28 Swedish
Notice of Saniona AB annual shareholders’ meeting
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an Annual General Meeting (AGM) for Saniona AB. It contains the agenda, proposals for board elections, remuneration guidelines, and instructions for shareholder participation. This document is a classic proxy statement/notice of meeting sent to shareholders to solicit their attendance and votes for the upcoming AGM. According to the provided definitions, this fits the Proxy Solicitation & Information Statement (PSI) category, as it provides the necessary information for shareholders to make informed voting decisions at the meeting.
2023-04-25 English
Kallelse till årsstämma i Saniona AB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Kallelse till årsstämma' (Notice of Annual General Meeting) for Saniona AB. It contains the agenda, proposals for board elections, remuneration guidelines, and instructions for shareholders to participate. This document is a standard proxy solicitation and information statement provided to shareholders ahead of an AGM.
2023-04-25 Swedish
Saniona’s partner Medix receives favorable opinion for tesofensine for the treatment of obesity and weight management in Mexico
Regulatory Filings Classification · 95% confidence The document is a press release issued by Saniona regarding a regulatory update for a partner's drug candidate (tesofensine) in Mexico. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As a general corporate announcement regarding business operations and regulatory status, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2023-02-25 English
Sanionas samarbetspartner Medix erhåller positivt yttrande om tesofensin för viktkontroll och behandling av fetma i Mexiko
Regulatory Filings Classification · 95% confidence The document is a press release from Saniona regarding a regulatory update for their partner Medix in Mexico. It is a short, news-oriented announcement (under 5,000 characters) that does not fit into specific financial reporting categories like 10-K or IR. As it is a general corporate announcement regarding business developments and regulatory news, it falls under the 'Regulatory Filings' (RNS) category.
2023-02-25 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Bokslutskommuniké' (Year-End Report) for Saniona AB for the period January–December 2022. It contains comprehensive financial statements, including income statements, balance sheet data, and detailed management commentary on business performance, pipeline status, and future outlook. It is a substantive financial report covering a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR) in the context of reporting periods shorter than or equal to a full year, as it provides the actual financial data and analysis rather than just an announcement of the report. FY 2022
2023-02-23 Swedish

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.